ImageneBio Inc (IMA) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 659K | 1.19M | 2M |
| Revenue Growth % | - | - | - | - | - | -100% | -100% | -100% | -100% | -87.91% | -81.49% | 424.61% |
| Cost of Goods Sold | 174K | 561K | 0 | 45K | 3.71M | 4.58M | 6.82M | 400K | 9.64M | 305K | 242K | 14.19M |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | 46.28% | 20.42% | 707.98% |
| Gross Profit | -174K | -561K | 0 | -45K | -3.71M | -4.58M | -6.82M | -400K | -9.64M | 354K | 943K | -12.18M |
| Gross Margin % | - | - | - | - | - | - | - | - | - | 53.72% | 79.58% | -607.98% |
| Gross Profit Growth % | 95.32% | 87.75% | 100% | 88.75% | 61.48% | -1393.79% | -823.01% | 96.72% | -281.54% | 103.47% | 107.58% | 19.34% |
| Operating Expenses | 11.9M | 7.94M | 26.59M | 8.71M | 7.08M | 7.94M | 5.59M | 15.42M | 8.58M | 22.26M | 20.45M | 6.31M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | 3378.15% | 1725.4% | 314.67% |
| Selling, General & Admin | 6.12M | -370K | 11.04M | 4.42M | 5.64M | 7.59M | 4.78M | 5.31M | 6M | 8.29M | 6.03M | 5.32M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | 1258.42% | 509.2% | 265.57% |
| Research & Development | 5.96M | 5.23M | 15.56M | 4.03M | 3.71M | 4.58M | 6.82M | 9.83M | 9.64M | 13.97M | 1.19M | 15.17M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | 2119.73% | 100% | 757.09% |
| Other Operating Expenses | -174K | 1000K | 0 | 264K | -1000K | -1000K | -1000K | 283K | -1000K | 0 | 1000K | -1000K |
| Operating Income | -12.08M | -8.5M | -26.59M | -8.75M | -10.79M | -12.52M | -12.41M | -15.82M | -18.23M | -21.91M | -19.5M | -18.49M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | -3324.43% | -1645.82% | -922.65% |
| Operating Income Growth % | -11.9% | 32.06% | -114.35% | 44.7% | 40.78% | 42.87% | 36.38% | 14.42% | -17.47% | -44.95% | -9.1% | 11.75% |
| EBITDA | -12.08M | -7.94M | -24.76M | -8.66M | -10.71M | -12.43M | -12.32M | -15.73M | -18.01M | -21.6M | -19.26M | -18.25M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | -3278.15% | -1625.4% | -910.58% |
| EBITDA Growth % | -12.81% | 36.09% | -101% | 44.93% | 40.54% | 42.47% | 36.05% | 13.79% | -17.82% | -44.95% | -9.05% | 12.28% |
| D&A (Non-Cash Add-back) | 0 | 561K | 0 | 87K | 87K | 89K | 90K | 92K | 219K | 305K | 242K | 242K |
| EBIT | -12.08M | -8.5M | -24.76M | -8.44M | -9.36M | -12.18M | -11.6M | -15.14M | -15.64M | -21.91M | -19.5M | -18.49M |
| Net Interest Income | 1.13M | 2.44M | 1.1M | 1.29M | 1.42M | 1.57M | 1.77M | 1.92M | 2.11M | 975K | 2.16M | 0 |
| Interest Income | 1.13M | 2.44M | 1.2M | 1.29M | 1.42M | 1.57M | 1.77M | 1.92M | 2.11M | 2.27M | 2.16M | 0 |
| Interest Expense | 0 | 0 | 96K | 0 | 0 | 0 | 0 | 0 | 0 | 1.3M | 0 | 0 |
| Other Income/Expense | 1.47M | 1.32M | 1.74M | 6M | 2.2M | 3.45M | 2.18M | 2.15M | 2.11M | 2.26M | 2.16M | 1.38M |
| Pretax Income | -10.61M | -7.18M | -24.85M | -2.75M | -8.59M | -9.07M | -10.22M | -13.67M | -16.12M | -19.65M | -17.34M | -17.11M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | -2981.94% | -1463.54% | -854.04% |
| Income Tax | 10K | -276K | -74K | 15K | 28K | 53K | 10K | 62K | 27K | -162K | 0 | 0 |
| Effective Tax Rate % | -0.09% | 3.84% | 0.3% | -0.55% | -0.33% | -0.58% | -0.1% | -0.45% | -0.17% | 0.82% | 0% | 0% |
| Net Income | -10.62M | -6.91M | -24.78M | -2.77M | -8.62M | -9.12M | -10.23M | -13.73M | -16.15M | -19.49M | -17.34M | -17.11M |
| Net Margin % | - | - | - | - | - | - | - | - | - | -2957.36% | -1463.54% | -854.04% |
| Net Income Growth % | -23.2% | 24.29% | -142.12% | 79.85% | 46.62% | 53.18% | 40.99% | 19.78% | -13.55% | -38.25% | -0.03% | 16.48% |
| Net Income (Continuing) | -10.62M | -6.91M | -24.78M | -2.77M | -8.62M | -9.12M | -10.23M | -13.73M | -16.15M | -19.49M | -17.34M | -17.11M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.95 | -0.62 | -3.01 | -0.06 | -0.18 | -0.19 | -0.21 | -0.28 | -0.33 | -0.41 | -0.40 | -0.43 |
| EPS Growth % | -427.78% | -226.32% | -1333.33% | 79.54% | 45.45% | 53.66% | 47.5% | 34.88% | 15.38% | -13.89% | 13.04% | 21.82% |
| EPS (Basic) | -0.95 | -0.62 | -3.01 | -0.06 | -0.18 | -0.19 | -0.21 | -0.28 | -0.33 | -0.41 | -0.40 | -0.43 |
| Diluted Shares Outstanding | 11.21M | 11.18M | 8.53M | 48.26M | 48.26M | 48.26M | 48.26M | 48.26M | 48.26M | 47.81M | 43.44M | 43.44M |
| Basic Shares Outstanding | 11.21M | 11.18M | 8.53M | 48.26M | 48.26M | 48.26M | 48.26M | 48.26M | 48.26M | 47.81M | 43.44M | 43.44M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |